Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

Same-day discharge after PCI for NSTE-ACS is on the rise
Sunil Rao, MD, told Cardiovascular Business that same-day discharge is still relatively rare for these patients, but it appears to be growing more common over time. The COVID-19 pandemic appears to have played a key role in the development of this trend.
RSNA seeking new editor for cardiothoracic imaging journal
RSNA is looking for a replacement for Suhny Abbara, MD, who is now the editor-in-chief of its flagship journal.
CCTA continues to transform cardiac imaging, interventional cardiology
Mirvat Alasnag, MD, spoke to Cardiovascular Business about CCTA's growing influence in cardiology.
Key trends in medical imaging systems at RSNA 2025
Sarah-Jane James, imaging market analyst for Signify Research, discusses key trends in the specialty that she saw at the Radiological Society of North America's annual meeting.
FDA clears next-generation platform for AI-enabled ECG evaluations
AccurECG 2.0 was designed to interpret a total of 13 different rhythm classifications, including atrial fibrillation, atrial flutter and ventricular tachycardia.

Sunil Rao, MD, MSCAI, director, interventional cardiology, cardiac catheterization laboratory, NYU Langone Heart, professor, Department of Medicine, the Leon H. Charney Division of Cardiology, NYU Grossman School of Medicine, explains the prevalence, trends and predictors of same day discharge after percutaneous coronary intervention (PCI) data for non-ST-elevation acute coronary syndrome (NSTE-ACS) in clinical practice from the NCDR-CathPCI Registry.

Same-day discharge after PCI for NSTE-ACS is on the rise

Sunil Rao, MD, told Cardiovascular Business that same-day discharge is still relatively rare for these patients, but it appears to be growing more common over time. The COVID-19 pandemic appears to have played a key role in the development of this trend.

RSNA seeking new editor for cardiothoracic imaging journal

RSNA is looking for a replacement for Suhny Abbara, MD, who is now the editor-in-chief of its flagship journal.

Mirvat Alasnag, MD, FACP, FACC, FSCAI, FSCCT, director of catheterization laboratory and research, King Fahd Armed Forces Hospital, Jeddah-Saudi Arabia, director of TCT Middle East, and member of Society of Cardiovascular CT (SCCT) Education Committee, outlines why coronary CT angiography (CCTA) imaging will likely be a paradigm shift in cardiology, and where the gaps remain to gather more clinical evidence.

CCTA continues to transform cardiac imaging, interventional cardiology

Mirvat Alasnag, MD, spoke to Cardiovascular Business about CCTA's growing influence in cardiology.

Sarah-Jane James, CT, MRI, molecular imaging senior market analyst for Signify Research, explains key trends in imaging systems she saw at the Radiological Society of North America (RSNA) 2025 meeting.

Key trends in medical imaging systems at RSNA 2025

Sarah-Jane James, imaging market analyst for Signify Research, discusses key trends in the specialty that she saw at the Radiological Society of North America's annual meeting.

AI healthcare doctor surgery procedure artificial intelligence

FDA clears next-generation platform for AI-enabled ECG evaluations

AccurECG 2.0 was designed to interpret a total of 13 different rhythm classifications, including atrial fibrillation, atrial flutter and ventricular tachycardia.

The U.S. Food and Drug Administration (FDA) has granted UltraSight an expansion of its Echo Stewardship Platform compatibility with additional ultrasound system types. This enables deployment of artificial intelligence (AI) guidance for focused cardiac ultrasound (FoCUS) across an entire healthcare system without the need to buy new ultrasound systems. The move enables health systems to expand use of the AI on compatible equipment they already own, including handheld, laptop and cart-based systems.

FDA clears expanded use of AI that helps novice users perform echo exams

This update helps health systems get more value out of UltraSight's advanced AI technology—all without buying brand new ultrasound equipment.

Video interview with ASE President David Weiner explains goals of society in 2026. #ASE

ASE president outlines need to lead on AI, sustain echo workforce

ASE President David Wiener, MD, discussed his goals for 2026 in a new video interview. "The imager who doesn't use artificial intelligence will be replaced by the imager who does,” he said.

Aetna covers AI-powered coronary plaque assessments, joining other major insurers

This news follows similar announcements from Humana, Cigna and UnitedHealthcare; a majority of insured Americans can now be treated with these technologies and have the procedure covered by their provider.